Back to today’s briefing

Story perspectives

CDC, FDA Collaborate with WHO on Flu Vaccine Amid Trump Ban

2/25/2025

45 11

Center

CDC and FDA Collaborate

In a pivotal meeting in London, the CDC and FDA engaged with the WHO to discuss flu vaccine strains, defying the Trump administration's communication ban. This collaboration is vital for setting vaccine targets for the upcoming season, raising alarms about how the U.S. withdrawal from the WHO could jeopardize vaccine effectiveness and public health.

Right

CDC Delays Meeting

The CDC has delayed its crucial ACIP meeting, sparking worries over vaccine deliberations. This gathering, intended to be the first under new HHS Secretary Robert F. Kennedy, was poised to usher in a new era of "radical transparency" in health communications, focusing on informed consent and teamwork to tackle chronic diseases plaguing the nation.

1 of 2

CDC and FDA Collaborate

In a pivotal meeting in London, the CDC and FDA engaged with the WHO to discuss flu vaccine strains, defying the Trump administration's communication ban. This collaboration is vital for setting vaccine targets for the upcoming season, raising alarms about how the U.S. withdrawal from the WHO could jeopardize vaccine effectiveness and public health.

1 / 2